IPO Summary: Medline’s Mega IPO Marks Major Win to Close out 2025 Calendar
Medline Inc. (MDLN): Blockbuster Debut Caps 2025 With a Statement Win Medline (MDLN US) delivered a resounding finish to the 2025 IPO calendar, pricing and trading with conviction in what became the year’s largest and most consequential public offering. The company priced an upsized offering of 216.034 million shares at $29.00, in the upper half of[…]
